<?xml version="1.0" encoding="UTF-8"?>
<p id="p0015">In addition, the Shi group isolated SARS-CoV-2 from the bronchoalveolar lavage fluid of a diseased patient [
 <xref rid="bb0005" ref-type="bibr">1</xref>]. The virus propagated on monkey and human cells and, notably, parallel investigations by others demonstrated that SARS-CoV-2 also productively infected primary human airway epithelial cells [
 <xref rid="bb0015" ref-type="bibr">3</xref>]. Using 
 <italic>in vitro</italic> infection assays, Zhou 
 <italic>et al.</italic> discovered that convalescent sera from surviving patients convincingly neutralized infections [
 <xref rid="bb0005" ref-type="bibr">1</xref>]. Moreover, in an initial assessment of broad antibody-mediated protection, they found that horse anti-SARS-CoV serum cross-neutralized SARS-CoV-2 infections [
 <xref rid="bb0005" ref-type="bibr">1</xref>]. Therefore, one can be optimistic about the prospects for broad antibody-mediated immunity against current and future zoonotic SARS-related CoVs, although much work lies ahead to identify vaccines that can elicit appropriate neutralizing antibodies.
</p>
